Knight Therapeutics Inc. GUD

Updated: 9 Aug 2026

TSX | Biotech | Pharmaceuticals

No signal published yet

We already track Knight Therapeutics and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Knight Therapeutics free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
TSX
Type
Biotech
Sector
Pharmaceuticals
We're already tracking Knight Therapeutics Inc. — here are the latest events we've registered

Recent News

  • On August 6, 2026, Knight Therapeutics reported its second quarter 2026 financial results, delivering revenues of CAD 144.2 million, up 34% year-over-year. The company also raised its full-year 2026 revenue guidance to between CAD 540 million and CAD 560 million.

What Firelda Watch includes for Knight Therapeutics Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Knight Therapeutics Inc. will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Bioarctic
BIOA B
BUY
Recipharm
RECI B
NEUTRAL
Viatris Inc.
VTRS
HOLD
Xbrane Biopharma AB (publ)
XBRANE
HOLD
AstraZeneca PLC
AZN
HOLD

Biotech

More companies in this sector

Want to follow Knight Therapeutics Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Knight Therapeutics free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Knight Therapeutics Inc. GUD
Knight Therapeutics — follow and we'll monitor it
Follow Knight Therapeutics free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.